Source: http://www.google.com/patents/US20020022885?dq=5537618
Timestamp: 2015-05-06 08:34:15
Document Index: 699414468

Matched Legal Cases: ['art 31', 'art 32', 'art 31', 'art 31', 'art 32', 'art 31', 'art 31', 'art 31', 'art 31', 'art 32', 'art 31', 'art 31', 'art 32', 'art 31', 'art 32', 'art 32', 'art 32', 'art 32', 'art 32', 'art 31', 'art 32', 'art 31', 'art 32', 'art 32', 'art 31', 'art 32', 'art 31', 'art 32', 'art 31', 'art 31', 'art 32', 'art 31', 'art 31', 'art 32', 'art 31', 'art 31', 'art 31', 'art 31', 'art 31', 'art 32', 'art 31', 'art 31', 'art 32', 'art 31', 'art 32', 'art 35', 'art 31', 'art 31', 'art 32', 'art 32', 'art 32', 'art 31', 'art 32', 'art 32', 'art 32', 'art 31', 'art 32', 'art 31', 'art 32', 'art 31']

Patent US20020022885 - Biomaterial - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsA porous body is a calcium phosphates sintered body having a number of substantially globular pores 1. A porosity is not less than 55% and not more than 85%, and simultaneously, and a mean pore diameter is not less than 50 μm and not more than 800 μm. A pore 11 having a size larger than the mean pore...http://www.google.com/patents/US20020022885?utm_source=gb-gplus-sharePatent US20020022885 - BiomaterialAdvanced Patent SearchPublication numberUS20020022885 A1Publication typeApplicationApplication numberUS 09/854,671Publication dateFeb 21, 2002Filing dateMay 15, 2001Priority dateMay 19, 2000Also published asDE60133432D1, DE60133432T2, EP1155705A2, EP1155705A3, EP1155705B1Publication number09854671, 854671, US 2002/0022885 A1, US 2002/022885 A1, US 20020022885 A1, US 20020022885A1, US 2002022885 A1, US 2002022885A1, US-A1-20020022885, US-A1-2002022885, US2002/0022885A1, US2002/022885A1, US20020022885 A1, US20020022885A1, US2002022885 A1, US2002022885A1InventorsTakahiro OchiOriginal AssigneeTakahiro OchiExport CitationBiBTeX, EndNote, RefManReferenced by (17), Classifications (12), Legal Events (1) External Links: USPTO, USPTO Assignment, EspacenetBiomaterial
US 20020022885 A1Abstract
A porous body is a calcium phosphates sintered body having a number of substantially globular pores 1. A porosity is not less than 55% and not more than 85%, and simultaneously, and a mean pore diameter is not less than 50 μm and not more than 800 μm. A pore 11 having a size larger than the mean pore diameter has at least three communicating pores 2 having a diameter of not less than 5 μm, on the average, and simultaneously, a pore having at least the three communicating pores 2 has at least one communicating pore 2 having a diameter of not less than 25 μm, on the average. The total opening area of the communicating pore 2 which is possessed by the pore 11 having a size larger than the mean pore diameter occupies the ratio of not more than 50% of the pore surface area. In a dry state, it is possible to wet the whole the porous body by dropping water and blood. Images(27) Claims(42)
BRIEF DESCRIPTION OF THE DRAWINGS [0078]FIG. 1 is a photomicrograph enlarging a cross section of a biomember of an embodiment of the present invention; [0079]FIG. 2 is a diagram showing main pores in FIG. 1; [0080]FIG. 3 is a diagram showing pores having a size larger than a mean pore diameter in FIG. 1; [0081]FIG. 4 is a diagram showing pores and communicating pores in FIGS. 1 and 3; [0082]FIG. 5 is an enlarged photograph in which resins are embedded in pores; [0083]FIG. 6 is an enlarged photograph in which resins are embedded in pores; [0084]FIG. 7 is a diagram showing a biomember buried in vivo; [0085]FIGS. 8A and 8B are diagrams showing a biomember buried in vivo, respectively; [0086]FIG. 9 is a diagram showing a biomember coated by active materials; [0087]FIG. 10 is a diagram showing a biomember coated by active materials and buried in vivo; [0088]FIG. 11 is a diagram of a biomember which active materials are coated, cells are introduced into and is cultured in an artificial environment; [0089]FIG. 12 is an enlarged photograph showing a cross section of the biomember presenting the other embodiment; [0090]FIG. 13 is a graph showing the state of a pore distribution in the other embodiment having a mean pore diameter of 300 μm; [0091]FIG. 14 is a graph showing the state of a pore distribution in the other embodiment having a mean pore diameter of 190 μm; [0092] FIGS. 15 to 23 show the other various embodiments of the present invention; [0093]FIG. 24 is a photomicrograph enlarging a cross section of the biomember in FIG. 1; [0094]FIG. 25 is a photomicrograph further enlarging a cross section of the biomember of FIG. 24; and [0095]FIG. 26 is a photomicrograph further enlarging a cross section of the biomember of FIG. 25. DETAILED DESCRIPTION OF THE EMBODIMENTS [0096] Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings. [0097] Embodiments of FIGS. 1-14 [0098] The biomember according to an embodiment of the present invention is comprised of a porous calcium phosphates sintered body, has no bio-harmfulness, and has relatively the strength even if it is a porous substance. What the porosity is not less than 55% and not more than 85% can enlarge a surface area of pores while maintaining the strength, and is very suitable for the biomember. Preferably, it is not less than 65% and not more than 85%. [0099] In addition, what a pore diameter is not less than 50 μm and not more than 800 μm on the average is used. In up to 50 μm is used, cell infiltration is difficult, and in more than 800 μm, strength deterioration and decrease of a pore surface area occur. Preferably, a mean pore diameter is not less than 100 μm and not more than 600 μm, and more preferably, not less than 100 μm and not more than 350 μm. [0100] For example, a microphotograph of a cross section of a biomember comprising 100% hydroxyapatite and having a mean pore diameter of 300 μm is shown in FIG. 1, and the one having a mean pore diameter of 150 μm is shown in FIG. 12. Also, in FIG. 2, main pores 1 existing in the cross section in FIG. 1 are plotted, and in FIG. 3, only pores 11 having a size larger than the mean pore diameter in FIG. 2 are plotted. And, in FIG. 4, in the inner surface of the pore 11 in FIG. 3, opened parts (communicating pores 2) that communicate with other pores 1 are plotted two-dimensionally by hatching. Further, in FIG. 2-FIG. 4, numeral 8 represents hydroxyapatite. [0101] As known clearly from these drawings, the biomember of the present invention has a number of pores 1, and the pores 1 are formed in a substantially globular shape as a whole. The globular pore 1 has no directional property, and is easy to maintain the strength. Also, the pores 1 are formed in a substantially globular shape, but when communicating pores 2 are formed in an interface by coming into contact with adjacent pores 1, a flat configuration becomes the same configuration as an outline when two circles are overlapped partially. [0102] Using such configuration is in order to enlarge a surface area. Even after sintering, an edge (open pore) remains sharply on the circumference of communicating pores 2, which are an interface of pores 1, 1 of the biomember. But, the edge may be removed a little by etching etc. so as to easily flow body fluid such as blood etc. [0103] Further, in the pores 1, pores 11 having a size larger than the above-mentioned mean pore diameter have at least three communicating pores 2 having a diameter of not less than 5 μm, on the average�they have communicating pores 2 having a diameter of not less than 5 μm in the ratio of at least three points on the average�and therefore, body fluid is impregnated everywhere. In addition, what a diameter of one communicating pore 2 is 5 μm �on the average� etc. defines the diameter in case of converting a transverse section configuration of the communicating pore 2 into a complete circle of the same transverse section volume. Also, since a pore having at least three communicating pores 2 on the average has at least one communicating pore 2 having a diameter of not less than 25 μm, on the average, cells are easy to infiltrate into pores 11 in addition to the body fluid. [0104] Generally, since human cell has a size close to 10 μm and an erythrocyte of an adult is also 8-9 μm in diameter, if there are communicating pores 2 of 25 μm, it is enough that oxygen or nutrients spread uniformly and cells penetrate. By having such large communicating pores 2 and communicating with many pores 11 three-dimensionally, body fluid circulates better in the whole biomember, and a cell easily infiltrates into a core part of the biomember. Additionally, since the circulation is enhanced remarkably by a communicating pore 2 of not less than 40 μm, such setting is preferable. [0105] Preferably, pores 11 having a size larger than the mean pore diameter have at least four communicating pores 2 having a diameter of not less than 5 μm, on the average, and among them, it is preferable to have at least one communicating pore 2 having a diameter of not less than 50 μm, on the average. More preferably, pores 11 having a size larger than the mean pore diameter have at least six communicating pores 2 having a diameter of not less than 10 μm, on the average, and among them, by having at least two communicating pores 2 having a diameter of not less than 50 μm, on the average, circulation of body fluids into pores 11 becomes active. In addition, it is particularly preferable that the foregoing (at least two points on the average) communicating pore 2 having a diameter of not less than 50 μm has a diameter of not less than 80 u m. [0106] However, it is preferable that pores 11 having the foregoing large communicating pore 2 and a size larger than the mean pore diameter are opened as the communicating pore 2 in the ratio of not more than 50% of a pore inner surface area (in other words, the total opening area of the communicating pore 2 which is possessed by the pore 11 having a size larger than the mean pore diameter occupies the proportion of not more than 50% of the pore surface area on the average). If the pore inner surface area to be lost as communicating pores 2 is larger than 50%, a surface area to attach cells becomes too small. Further, it also affects strength. Preferably, it is not more than 40%. [0107] In satisfying the foregoing conditions, the pore inner surface should be wet in detail by water or blood in order that body fluid or cells infiltrate easily. In this regard, as mentioned in the above, because the present invention uses pores 11 of the specific state and it has a homogeneous structure through inner part, a sintered body which is processed if necessary and then washed and dried can soak water by a capillary phenomenon in a dry state without carrying pretreatment, for example, if a part is immersed in water (pure water). Also, it has characteristics that it is possible to flow through an inner part to reach a bottom part by dropping water. It is particularly preferable that blood (whole blood) is the same as water. [0108] In addition, the �in a dry state� means no treatment such as coating of surfactants or previous wetting by priming etc., and it is possible to use without pretreatment for a living body. However, this expression is not the meaning of limiting a practical using method. Also, various limitations relating to pores 11 having a size larger than the mean pore diameter are because pores 11 having a size larger than approximately the mean pore diameter substantially affect extremely the effects etc. [0109] By the way, the mean pore diameter described in the present invention can be measured, for example, by resin embedding (filling pore 1 with resin). And, the 50% volume pore diameter i.e., a diameter of a pore when the value is exactly 50% of total pores by integrating volumes in a large pore (or a small pore) is referred to as the mean pore diameter. Additionally, the state that pore 1 is filled with resin 3 is shown in FIG. 5 and FIG. 6. As a result of measurement, FIG. 5 shows that the mean pore diameter is 190 μm, and FIG. 6 shows that the mean pore diameter is 300 μm. [0110] Also, in any plain cross section, when observing the state of pore 1 in plane aspect, pores 11 having a size larger than the mean pore diameter is preferably not less than 25% and not more than 60% of a flat area. That is, a sum of area of pores 11 shown in FIG. 3 is not less than 25% and not more than 60% of a total area in FIG. 3. In up to 25%, since pore parts become smaller, cell infiltration becomes difficult, and in more than 60%, strength is liable to be weak. More preferably, it is not less than 35% and not more than 55%. Still more preferably, it is not less than 40% and not more than 50%. [0111] In the biomember of the present invention, because a cylinder part of the communicating pore 2 formed causing a pore 11 to overlap with a pore 11 having a size larger than the mean pore diameter, that is, the above-mentioned edge (open pore) is formed sharply and thin in about the thickness of one calcium phosphate particle to enlarge surface area, it is believed that the thin formed part (edge) is substituted promptly for a bone. [0112] Such characteristics of pores 1 (11) can be obtained from foaming by stirring slurry raw material, and then, drying and sintering. Since the pore is not formed by baking and taking-out using globular particles of polystyrene etc., pressure for forming is not needed, there is no directional property that pores 1 (11) become plain, etc., and simultaneously, compared with that a contact point of polystyrene is opened, in the present invention, the communicating pore 2 becomes remarkably large, and simultaneously, a surface area can be enlarged. Additionally, it is preferable that in calcium phosphate particles of slurry raw materials, a mean particle diameter is of the submicron order (i.e., not less than 0.1 μm and up to 1 μm), and it is preferable that the maximum particle diameter is also of the submicron order. [0113] In addition, for example, Japanese Patent Laid-Open No. hei 10-167853 describes a porous body that a circumferential part of a communicating pore is formed sharply, but because it is made by baking and taking-out, the communicating pore is small not more than 10 μm, and it is difficult that a cell penetrates. [0114] The biomember of the present invention can be processed into a desired shape, and at the same time, fixed in vivo, and thus, blood etc. infiltrate the inner part and oxygen or nutrients spread uniformly. If body fluid such as blood etc. circulate, cells begin to be attached to the inner wall surface of the member. The biomember of the present invention has a large surface area, and has many chances that cells are attached. Also, since pores 11 having a size larger than the mean pore diameter have open pore parts of not less than 25 μm, blood etc. are easy to infiltrate inwardly. By having the open pore parts to be not less than 40 μm, blood etc. are easy to remarkably infiltrate inwardly. [0115] Since pores 1 are connected with each other, an inner part of the member begins to be substituted for the bone promptly. Since blood spread fast and uniformly as a whole mainly through pores 11 having a size larger than the mean pore diameter, blood etc. spread uniformly in small pores 1 having a size less than the mean pore diameter as similar as large pores 11. [0116] In the biomember of the present invention, the maximum pore diameter is preferably within three times of the mean pore diameter. Locally, too large pore are not preferable in strength and cell adhesion. Preferably, it is within two times thereof. The graph of FIG. 13 is a cumulative volume fraction of a sintered body pore having the mean pore diameter of 300 μm. The graph of FIG. 14 is also a cumulative volume fraction of sintered body pore having the mean pore diameter of 190 μm. In all, not less than 50% of the total pores are included within a range of �30% of the mean pore diameter. [0117] As such, in the present invention, not less than 50% of the total pores are preferably included within a range of �30% of the mean pore diameter. Also, the cumulative volume fraction of pore of not more than 20 μm is preferably approximately 0, and further, even if a skeleton surface of a calcium phosphate porous body is observed microscopically, there hardly exist pores, and it is preferable that there exists only unevenness by rounding of calcium phosphate particles. [0118] The biomember is preferably comprised of hydroxyapatite particularly excellent in strength. Its purity is preferably at least 98%, and in particular, 100% is good. Such a member can be obtained from, for example, Toshiba Ceramics Co., Ltd. [0119] Further, as such, in the present invention, various materials suitable for forming bones are coated in the pore inner surface by using the features that blood etc. are easy to infiltrate into inner part as a whole, that a communicating pore is large, and that a surface area is large. The coated materials are active materials such as cell adhesion promoting material, cell proliferation promoting material, osteogenesis promoting material, bone absorption inhibiting material, vascularization promoting material and so forth, or cells and cells in which a genetic recombination is performed. [0120] They are in a liquid phase or cultured in a broth, and infiltrate everywhere by using the features of the biomember of the present invention. In general, they easily spread uniformly as a whole by immersion, but in case where cells are big or have a high viscosity by a cell culture, they can be sucked by applying a negative pressure on a side where the biomember is present. [0121] In any case, by using a biomember having both excellent penetrating property and excellent adhesive property to the surface with regard to the whole, they can spread uniformly and consistently to a core part even in a thick member, while it was impossible in the conventional product. [0122] Hydroxyapatite has strong adsorptivity, and in particular, protein or anchorage dependent cells are easily adsorbed on the surface of hydroxyapatite. In addition, even in case where it is difficult to be adsorbed by simple contact, cell adhesive protein such as laminin etc. or heparin etc. is previously added to hydroxyapatite, and then, it is more preferable that an active material or a cell to be attached is added. [0123] The active material may be cell adhesive promoting material. The cell adhesive promoting material is used as a term including �a constitutional element of an extracellular matrix� and �adhesive molecules�. The constitutional element of the extracellular matrix includes (1) a basal membrane, (2) fibrillar protein of collagen, elastin, etc., (3) cell adhesive glycoprotein of fibronectin, laminin, vitronectin, etc., (4) complex carbohydrates of glycosamidglycan etc. including heparin, hyaluronic acid, chondroitin sulfuric acid, but it is not limited thereto. [0124] Further, the adhesive molecule is the same meaning as a cell adhesive molecule, adhesive factor, and adhesive protein, and includes E-selectin, P-selectin, ICAM-1 (=intercellular adhesion molecule-1), VCAM-1, CD-18, CD-44, etc., but it is not limited thereto. [0125] Further, the active material may be cell proliferation promoting material. The cell proliferation promoting material means material exhibiting physiological activities such as growth, division, differentiation of cell and functional promotion, etc., and includes �a proliferation factor� and �a mitogenic factor�. The proliferation factor is the same meaning as a growth factor, and includes TGF-β superfamily, HGF (=hepatocyte growth factor), etc., but it is not limited thereto. Further, mitogenic factor is the same meaning as mitogen, and includes lectins of concanavalin A etc., but it is not limited thereto. [0126] Further, the active material may be osteogenesis promoting material. The osteogenesis promoting material (it is called osteogenic factor) is BMP family, TGF-β superfamily, SAMP8 and so forth. Also, the active material may be bone absorption inhibiting material. The bone absorption inhibiting material is caldeclin etc. [0127] Or, the active material may be vascularization promoting material. The vascularization promoting material is VEGF (=vascular endothelial growth factor), PDGF (=platelet-derived growth factor), b-FGF (b-fibroblastic growth factor), VEGF receptor (Flt-1 (VEGFR-1), Flk-1 (VEGFR-2), Flt-4 (VEGFR-3)), angiopoitin family receptor, trehalose 6,6′-dimycolate (=TDM, TIE2/TEK, TIE1) and so forth. [0128] And, the active material may be a combination comprising at least two of cell adhesive promoting material, cell proliferation promoting material, osteogenesis promoting material, bone adsorption inhibiting material and vascularization promoting material. The active material is a liquid phase, and is formed easily as a film phase on pore surface by immersing a biomember or bring it into contact. Then, it may be dried and can be preserved for a long time by refrigeration or cold preservation. Of course, it may be used instantly without preservation. [0129] Further, an osteogenic cell may be introduced into the pore 1 (11). The osteogenic cell may be an osteoblast, and may include a chondrocyte. Just as it is taken out from a living body, or the osteogenic cell is previously introduced into the biomember described in claims 1 to 10 in vivo or in vitro, as it is, or the osteogenic cell to be re-cultured is applied to a patient. Thereby, after the operation, recovery that should be made for several days or weeks in vivo by the patient for himself/herself will be beforehand performed in vitro. [0130] Or, an automyelocyte may be introduced into the pore 1 (11). In particular, when using the automyelocyte, of course, there is neither rejection reaction nor concern of infection by diseases such as hepatitis etc. But, in case of the aged etc., when a cell itself of the patient has no vitality, excellent effects cannot be expected. [0131] Further, a homogeneous myelocyte may be introduced into the pore 1 (11). When using the homogeneous myelocyte to which another person's cell is introduced, the cell of the operated region can have vitality though the cell of the person himself/herself has no vitality. [0132] Further, a fetal myelocyte may be introduced into the pore 1 (11). Or, an undifferentiated stem cell may be introduced into the pore. The undifferentiated stem cell is, for example, ES cell (=Embryonic stem cell), EG cell (=Embryonic germ cell) and so forth. [0133] Further, if an osteogenic cell, automyelocyte, homogeneous myelocyte, fetal myelocyte or undifferentiated stem cell is introduced into the member to which at least one or two of the foregoing active materials are attached, the actions of the cell can be more active. [0134] Or, an osteogenic cell to which gene of active factor is introduced may be introduced into the pore 1 (11). The active factor enables activation of growth, division, differentiation of a cell and functional promotion, etc. such as TGF-β, BMP, HGF, EGF and so on, and a suitable one is chosen if necessary. Since they are incorporated into a cell in a genetic level, the osteogenic cell gets to act actively. [0135] Further, an automyelocyte to which a gene of an active factor is introduced may be introduced into the pore 1 (11). As mentioned in the above, in case of the automyelocyte, there is neither rejection reaction nor concern of infection, and even in the aged, his/her own cell gets to act actively by genetic recombination. [0136] Further, a homogeneous myelocyte to which a gene of an active factor is introduced may be introduced into the pore 1 (11). A fetal myelocyte to which a gene of an active factor is introduced may be introduced into the pore 1 (11). Or, an undifferentiated stem cell to which a gene of an active factor is introduced may be introduced into the pore 1 (11). [0137] Further, an automyelocyte to which a gene of an active factor is introduced, homogeneous myelocyte to which a gene of an active factor is introduced, fetal myelocyte to which a gene of an active factor is introduced or undifferentiated stem cell to which a gene of an active factor is introduced may be introduced into the member to which at least one or two of the foregoing active materials are attached. The combinations thereof exhibit the greatest effect in the present invention. [0138] Further, by filling or coating drugs to pore the inner surface of the biomember of claims 1 to 10, for example, by means of immersion, impregnation, aspiration and so on, sustained release preparations can be made. At this time, after completion of sustained release, a calcium phosphates sintered body may be taken out in vitro, and if possible, may be regenerated as a bone. [0139] Examples will be illustrated with reference to the embodiments of FIGS. 1 to 14 of the present invention. EXAMPLE 1 [0140] Prisms (10�20�40 mm) for a biomember comprising a sintered body of 100% of apatite, having a porosity of 75% and a mean pore diameter having the same pore shape as FIG. 1 and FIG. 12 is 300 μm and 150 μm were prepared, respectively; and 1 cc of blood dropped thereto, and then, it was absorbed immediately as if it droped on a sponge. EXAMPLE 2 [0141] Four types of cylinders comprising biomembers with Φ 10�6 mm (diameter 10 mm, length 6 mm) made of hydroxyapatite of the present invention, having a porosity of 75% and a mean pore diameter of 150 μm, 300 μm and 600 μm, respectively, and a similar hydroxyapatite biomember (comparative example) with Φ 10�6 mm made by A Pharmaceutical Company, having the porosity of 50% and the mean pore diameter of 100 μm were prepared; and about 200 μl of a culture solution (this is a liquid comprising amino acid or plasma containing many kinds of cytokines, and its viscosity is close to that of water) dropped to each of them, and then, all of three types of the biomembers of the present invention absorbed the entire solution like a sponge. And, the biomember of A Pharmaceutical Company (of comparative example) did not absorb the culture solution at all. EXAMPLE 3 [0142] On the biomember Φ 10�6 mm made of hydroxyapatite of the present invention, having a mean pore diameter of 300 μm, a cell suspension containing osteoblasts dropped, and then, the biomember absorbed it immediately like a sponge. Thereafter, under the conditions of 37� C. and 5% CO2, it was cultured for 2 days, and as the result of observing an inner part of the cylinder, adhesion of numberless cells was ascertained on the inner part. FIG. 7 shows the state that cells 4 are attached into the pore 1 (11). EXAMPLE 4 [0143] Three types of biomembers made of hydroxyapatite of the present invention, having a porosity of 75% and a mean pore diameter of 150 μm, 300 μm, 600 μm were prepared as cylinders of Φ 6�15 mm, respectively. [0144] They were embedded in a thighbone of a rabbit, and were taken out 1 week, 3 weeks, 6 weeks after operation; they were further fixed by formalin, and decalcificated, and then, stained by hematoxylin-eosin. With respect to the thus treated biomembers, tissue infiltration into hydroxyapatite and a bone neogenesis state were observed by an optical microscope. [0145] The results are shown below as (1)-(3). [0146] (1) 1 week after operation, a granulation tissue was ascertained in all of the pore inner parts of three types of the biomembers having a mean pore diameter of 150 μm, 300 μm, and 600 μm, and blood vessels were also partially observed. A bone neogenesis was a few detected in a surface layer of hydroxyapatite. [0147] (2) 3 weeks after operation, a bone neogenesis was shown up to an extremely deep core part (central part) of the cylinder of Φ 6 mm as if it sticks along the surface of the pores, and as the result of measuring the surface area of the bone neogenesis part, with respect to the mean pore diameters, 300 μm was somewhat larger than 600 μm, and 150 μm larger than 300 μm. In this time, with respect to ones having a larger pore diameter, blood vessels could be more clearly ascertained. Further, there existed a number of myelocytes on the central part of such a pore. [0148] (3) 6 weeks after operation, in addition to the bone neogenesis of (2), myelocytes were observed in the pores having all of the pore diameters. It is believed that they had hematogenous functions and became close to the state of a bone marrow before filling up hydroxyapatite. Also, in this step, as a result of measuring the strength of hydroxyapatite, it was enhanced to the extent of about two times than the case before filling it up. [0149]FIG. 8A shows the state that a small blood vessel 5 begins to be formed in a pore 1 (11) (but, the state of a cell was omitted). FIG. 8B shows the aspect that myelocytes 9 are generated in a pore 1 (11) (however, the aspect of blood vessels is ommitted). Comparative Example 1 Relative to Example 4 [0150] A member with a diameter of 6 mm and a length 15 mm, having the above-mentioned characteristics (A Pharmaceutleal Company's) was embedded in a thigh bone of a rabbit, and as the result of observing 3 weeks, 6 weeks after operation, adhesion with a cowl bone was ascertained on the surface of apatite, but tissue infiltration into an inner part was not shown at all. [0151] From the results of the above examples 1 to 4 and comparative example 1, the mean pore diameter of about 100-600 μm is useful for cell fixation or bone regeneration, and above all, it is preferable that a pore has a comparative small mean pore diameter of not less than 100 μm and not more than 350 μm. In particular, the mean pore diameter of not less than 120 μm and not more than 220 μm is superior. EXAMPLE 5 [0152] Two kinds of cylinders (a), (b) with Φ 10�6 mm; a cylinder (a) �no growth factor� and a cylinder (b) �adding 3 μg/block of VEGF vascular endothelial growth factor�, having a porosity of 75% and a pore diameter of 300 μm having the same pore configuration as FIG. 1 were grafted to a latissimus dorsi muscle subfascia of a mouse. Three weeks after grafting, they were taken out, and then, a tissue in apatite was observed. The results are shown below as (4) and (5). [0153] (4) In the cylinder with no growth factor, cell infiltration was merely about 1 mm in the surface layer of apatite. [0154] (5) In the cylinder adding VEGF, cell infiltration was observed up to an apatite core part (this means a cell infiltrated 3 mm-4 mm and more in the surface layer). [0155]FIG. 9 shows the state that an active material 6 was attached to a pore 1 (11). The active material 6 is illustrated exaggeratedly to easily understand the attached state, but in practical, even if protein etc. are coated, the thickness is sometimes hardly shown. In addition, if it is collagen etc., any degree of thickness can be ascertained. [0156]FIG. 10 shows the state that in the member of FIG. 9, a cell 4 was attached to the active material by an animal experiment. FIG. 11 shows the state that cell 4 is introduced into the member in FIG. 9, and many cells 4 were increased in a pore 1 (11) by culture. [0157] Further, the number etc. of cells in FIGS. 7 to 11 are indicated so as to understand relatively the respective characteristics, and the actual state is not accurately expressed. Substantially, the cell is visible slightly smaller, and the number thereof becomes also more numerous. [0158]FIG. 13 shows a pore distribution of the biomember in FIG. 1, and FIG. 14 shows a pore distribution of the biomember with a mean pore diameter of 190 μm, having the same pore as that of FIG. 1. [0159] The graphs of FIG. 13 and FIG. 14 represent the cumulative volume fractions of sintered body pores having a mean pore diameter of 300 μm and 190 μm. In the present invention, like the graphs, at least 50% of total pores volume is preferably included within a range of �30% of the mean pore diameter. Also, the cumulative volume fraction of pores of not more than 20 μm is preferably approximately 0, and additionally, it is preferable that in observing microscopically a skeleton surface of a calcium phosphate porous body, there hardly exist pores, and there exists only unevenness caused by rounding of calcium phosphate particle. [0160] It is preferable that pores are concentrated around the mean pore diameter such that a cumulative volume fraction included in the range of a pore diameter having a cumulative volume fraction of 50% to a 30% larger pore diameter than the pore diameter, that is, in the range of a pore diameter of 300 μm and 390 μm in the case of the mean pore diameter of 300 μm, is not less than 25%; and it is particularly preferable if not less than 30%. That is because these pores are the most important ones to obtain the effects of the present invention. [0161] By the way, in general, for example, when an old man of about 70 years suffers a fracture, depending on the fracture portion and fracture degree, it usually takes several weeks to one year to recovery. In particular, in fracture of a thighbone, it takes more time, and if a sick period becomes longer, a bedridden tendency is higher. [0162] In this regard, if the biomember of the present invention is used, the period in which an injury is healed will be decreased by half, estimated by a cell culture state, and by using genetic recombination technology, it is more reduced, and further, a patient who suffers inconvenience in a daily life due to deterioration of a bone density can be expect to recover. Further, it can be sufficiently applied to treat osteoporosis. [0163] In this manner, in the biomember of the present invention, because a substantially globular pore 1 (11) is formed and the shape of the globular pore is maintained in the area other than a communicating pore 2, the surface area per unit volume is remarkably large while the communicating pore 2 is secured, body fluid is penetrated into an inner part by a capillary phenomenon, and the proportion of contact with blood is high, and therefore, much more cells 4 can be easily attached. [0164] Further, since an active material 6 can be spread over the whole, and is easily attached on the surface, it is easily prepared to attach various active materials 6 or introduce cells, and furthermore, thereafter culture is also easy, and, remarkable recovery after operation will be possible by applying it to the patient. [0165] The biomember of the present invention can be not only used when a bone is defected but also applied to sustained-release preparations which are caused to indwell in vivo to release drugs for a long period. Also, a compact biomember may be arranged properly in order to enhance the strength in a core part or a part of the outer surface of a biomember. Even so, because circulation of body fluids is possible only in a porous part of the surroundings, the effects of the present invention can be sufficiently expected. Further, the shape of the biomember of the present invention may be various, and of course, if necessary, may be granular. [0166] Since it is comprised of a porous calcium phosphates sintered body, it has good compatibility with a living body, has no bio-harmfulness. And, since the porosity is set to be an appropriate value, the strength required for compensating the defected portion of a bone can be sufficiently secured. And, it can be properly processed into a necessary form, and furthermore, since a structure is homogeneous through an inner part, the member is of definite quality and of good reliability. [0167] The pores 11 communicate with each other through a communicating pore 2, and therefore, the surface area per unit volume can become larger, body fluid is penetrated into an inner part by an excellent capillary phenomenon, the proportion of contact with blood becomes high, much more cells 4 can be attached, and integration with a living body is performed promptly. [0168] Also, in order to enhance the strength etc., even if a compact member is properly arranged to the core part, circulation of body fluid is possible only in a porous part of the surroundings, and thus, extensive application can be made depending on symptoms. [0169] Also, the biomember can be not only applied in the case where a bone is defected, but also applied to sustained-release preparations which are caused to indwell in vivo to release drugs for a long period. In this case, if integration with a living body is possible, re-operation for enucleation is not needed. [0170] Because the mean pore diameter is set to be a more preferable value, a more excellent capillary phenomenon can be expected, and body fluid can be penetrated into an inner part more efficiently. [0171] Because the diameter of the communicating pore 2 is set to be a more preferable value, circulation of body fluid into the pore 1 (11) becomes more active. [0172] Because the ratio of the pore 11 having a size larger than the mean pore diameter occupied in a flat area is set to be a preferable value, infiltration of the cell 4 into the pore 1 (11) becomes easy, and simultaneously, the desired strength can be secured. [0173] Because the ratio of the pore 11 having a size larger than the mean pore diameter occupied in a flat area is set to be a more preferable value, infiltration of the cell 4 into the pore 1 (11) becomes further easy, and simultaneously, the desired strength can be more properly secured. [0174] Because water infiltrates into a core part by a capillary phenomenon, body fluid or cells can be impregnated to the core part. [0175] Because blood infiltrates into a core part by a capillary phenomenon, body fluid or blood can be impregnated to the core part. [0176] Because the thickness of a circumferential part of the communicating pore 2 becomes about the thickness of one calcium phosphate particle, the edge (open pore) is formed thin and sharply, and thus, the surface area becomes larger, and the thin part is easily substituted for a bone. [0177] Because the pore 1 is formed from foaming by stirring of a slurry, the pore becomes substantially globular, and a diameter of a communicating pore becomes enlarged. Also, a circumferential part of the communicating pore 2 is formed thin and sharply, and the surface area becomes larger, and therefore, the thin part is easily substituted for a bone. [0178] Because a calcium phosphates sintered body is comprised of hydroxyapatite 8, particularly, protein or anchorage dependent cells are easily attached on the surface. [0179] Because an osteogenic cell is introduced into the pore 1, after operation, recovery that should be made by a patient himself/herself for several days or weeks in vivo will be beforehand performed in vitro, and therefore fast recovery can be expected. [0180] Because an automyelocyte is introduced into the pore 1, there is neither rejection reaction, nor concern of infection by diseases of hepatitis etc. [0181] Because a homogeneous myelocyte is introduced into the pore 1, cells in an operated region can have vitality even though the cells of the person himself/herself have no vitality. [0182] Because a fetal myelocyte is introduced into the pore 1, actions of cells can be more active. [0183] Because an undifferentiated stem cell is introduced into the pore 1, actions of cells can be more active. [0184] Because an osteogenic cell to which a gene of an active factor is introduced is introduced into the pore 1, activation of growth, division and differentiation of cells, functional promotion, etc. becomes possible, and they are incorporated into cells in a genetic level, and therefore, osteogenic cells act actively. [0185] Because an automyelocyte to which a gene of an active factor is introduced is introduced into the pore 1, there is no fear of rejection reaction and concern of infection, and, even in the aged, his/her own cells can be caused to act actively by genetic recombination. [0186] Because a homogeneous myelocyte to which a gene of an active factor is introduced is introduced into the pore 1, cells in an operated region can have vitality even though the cells of the person himself/herself have no vitality. [0187] Because a fetal myelocyte to which a gene of an active factor is introduced is introduced into the pore 1, actions of cells can be more active. [0188] Because an undifferentiated stem cell to which a gene of an active factor is introduced is introduced into the pore 1, actions of cells can be more active. [0189] Because the active material 6 is attached to the inner surface of the pore 1, cells are easily attached. [0190] Because the active material 6 is cell adhesion promoting material, cells are easily adhered (adsorbed). [0191] Because the active material 6 is cell proliferation promoting material, cell proliferation is promoted. [0192] Because the active material 6 is osteogenesis promoting material, formation of a bone is promoted. [0193] Because the active material 6 is bone absorption inhibiting material, absorption of a bone is suppressed. [0194] Because the active material 6 is vascularization promoting material, vascularization is promoted. [0195] Because the active materials 6 are combinations comprising at least two of cell adhesion promoting material, cell proliferation promoting material, osteogenesis promoting material, bone absorption inhibiting material and vascularization promoting material, cell adhesion or cell proliferation becomes active, formation of a bone is promoted, or absorption of a bone is suppressed, and also, vascularization is promoted. [0196] Because an osteogenic cell is introduced, after operation, recovery that should be made by a patient himself/herself for several days or weeks in vivo will be beforehand performed in vitro, and fast recovery can be expected. [0197] Because an automyelocyte is introduced, there is no fear of rejection reaction and concern of infection by diseases of hepatitis etc. [0198] Because a homogeneous myelocyte is introduced, cells in an operated region can have vitality even though the cells of the person himself/herself have no vitality. [0199] Because a fetal myelocyte is introduced into the pore 1, actions of cells can be more active. [0200] Because an undifferentiated stem cell is introduced into the pore 1, actions of cells can be more active. [0201] Because an osteogenic cell to which a gene of an active factor is introduced is introduced into the pore 1, activation of growth, division and differentiation of cells, functional promotion, etc. become possible, and they are incorporated into cells in a genetic level, and therefore, osteogenic cells act actively. [0202] Because an automyelocyte to which a gene of an active factor is introduced is introduced into the pore 1, there is no fear of rejection reaction and concern of infection, even in the aged, his/her own cells can be caused to act actively by genetic recombination. [0203] Because a homogeneous myelocyte to which a gene of an active factor is introduced is introduced into the pore 1, cells in an operated region can have vitality even though the cell of the person himself/herself have no vitality. [0204] Because a fetal myelocyte to which a gene of an active factor is introduced is introduced into the pore 1, actions of cells can be more active. [0205] Because an undifferentiated stem cell to which a gene of an active factor is introduced is introduced into the pore 1, actions of cells can be more active. [0206] It can be used as sustained-release preparations. [0207] Embodiment of FIG. 15 [0208] In inserting a stem part of an artificial joint into a bone, an osteoepiphysis is removed, a hole for inserting the stem is formed by a drill etc., and then the stem is inserted to be fixed. The stem is generally made of titanium alloy etc., and is difficult to be compatible with a bone. For that reason, it takes time to be fixed to the bone, and meantime, since deviation is occurred whenever load is applied, a patient sometimes feels a pain. [0209] In the embodiments of the present invention, a calcium phosphates porous body having a specific pore shape is arranged on the outer surface of a portion where an artificial joint is inserted to a bone lobe. Thereby, it is easy to be compatible with the bone due to the specific pore shape, and accelerate fixation to mitigate pains at an early stage. [0210] When a porous body to form the outer surface of the biomember of the present invention is practically formed in a block shape and inserted into a bone lobe, regeneration of a bone begins in the region of the porous body, and the aspect is taken white in Roentgen, and it can be identified only in 3 weeks while it takes about three months in the conventional porous body. [0211] A compact member 21 is processed into a desired shape to be fixed in vivo. A porous member 22 is infiltrated by blood etc., and oxygen or nutrients are spread sufficiently. If body fluid such as blood, circulates, cells are easy to be attached to the inner wall surface of the member. [0212] The biomember of the present invention has a large surface area, and thus, there are many chances that cells are attached. Also, since large pores having a size larger than the mean pore diameter have an opening portion of at least 25 μm, blood etc. can easily infiltrate thereto. Because pores are connected with each other, any region of the inner part of the member begins to be quickly substituted for a bone. [0213] Since blood is spread fast over the whole, centering around pores having a size larger than the mean pore diameter, blood etc. are also spread uniformly as the same as the large pores even in small pores having a size smaller than the mean pore diameter. [0214] In the porous member of the biomember of the present invention, the maximum pore diameter is preferably within three times of the mean pore diameter. Locally too large pores are not preferable in strength and cell adhesion. Preferably, it is within two times thereof. [0215] The graphs of FIG. 13 and FIG. 14 accord with the embodiment of FIG. 15, too. [0216] The biomember of the present invention is preferably comprised of hydroxyapatite particularly excellent in strength among calcium phosphates sintered bodies. The purity is preferably at least 98%, and in particular, 100% is preferable. [0217] Further, as such, in the present invention, various materials suitable to form bones can be coated in the pore inner surface by using such features that blood etc are easily infiltrated as a whole and the surface area is large. [0218] As the coated materials, there are active materials such as cell adhesion promoting material, cell proliferation promoting material, osteogenesis promoting material, bone absorption inhibiting material, vascularization promoting material, etc., cells and genetic recombinant cells and so forth. [0219] They are in a liquid phase or cultured in a broth, and infiltrate everywhere by using the features of the biomember of the present invention. In general, they are easily panetrated over the whole by immersion, but when cells become big or have a high viscosity owing to cell culture, they can be sucked by applying a negative pressure on the side where the biomember is present. In any case, by using the biomember of the present invention having both excellent penetrating property over the whole and excellent adhesive property to the surface, they can be penetrated uniformly and consistently to a core part even in a thick member, which was impossible in the conventional product. [0220] Examples will be illustrated below with reference to the embodiment of FIG. 15 of the present invention. EXAMPLE 6 [0221] A hydroxyapatite film was formed on the outer surface of a titanium alloy rod having a diameter of 10 mm, a length of 100 mm and a porosity of 0 by spray coating, and a granular porous apatite layer having a mean particle diameter of 1 mm, a porosity of 75%, and a mean pore diameter of 150 μm was installed thereon by a thickness of 1.5 mm, and then, bonded by heating. EXAMPLE 7 [0222] A granular porous apatite layer having a mean particle diameter of 2 mm, a porosity of 75%, and a mean pore diameter of 300 μm was installed on the outer surface of a titanium alloy rod having a diameter of 10 mm, a length of 100 mm and a porosity of 0 through an adhesive by a thickness of 2.5 mm, and then, bonded. EXAMPLE 8 [0223] An apatite film was formed on the outer surface of an alumina rod having a diameter of 10 mm, a length of 100 mm and a porosity of 10% by spray coating, and a granular porous apatite layer having a mean particle diameter of 1 mm, a porosity of 75%, and a mean pore diameter of 150 μm was installed thereon by a thickness of 1.5 mm through a slurry containing apatite, and then, bonded by heating. EXAMPLE 9 [0224] A foamed slurry containing apatite was coated on the outer surface of an apatite rod having a diameter of 10 mm, a length of 100 mm and a porosity of 0, and sintered. Then a porous member 22 having a porosity of 75% and a mean pore diameter of 150 μm was installed by a thickness of 3 mm. EXAMPLE 10 [0225] A foamed slurry containing apatite was coated on the outer surface of an alumina column having a size of 10�10�100 mm and a porosity of 5%, and a previously sintered porous member 22 having a porosity of 75% and a mean pore diameter of 150 μm was bonded on one side of the column by a thickness of 2 mm, and then, heated. [0226] In any one of the examples 6-10, porous granules were fixed firmly to the compact body. Also, pores of the porous body maintained a specific shape. When blood dropped on these porous members 2, it was penetrated extensively in the whole of the porous members 2. [0227] In the biomember of the present invention, the respective pores 3 of the porous member 22 forming a part or the whole of the outer surface have a relatively equal size and they communicate with each other. Particularly, in pores having a size larger than the mean pore diameter, because communicating pores are large, infiltration of blood or cells is easy, regeneration of a bone begins at an early stage in the porous member 22 comprised of calcium phosphate, and a bone can be compatible with the compact member 21. [0228] Accordingly, while a communicating pore is secured, a surface area per unit volume is remarkably large, body fluid is penetrated into an inner part by a capillary phenomenon, the proportion of contact with blood is high, and therefore, much more cells can be easily attached. [0229] Further, active material etc. can be penetrated over the whole, and be easily attached to the surface, and therefore, it is easily prepared to attach various active materials or introduce cells, and furthermore, thereafter, culture is easy and remarkable recovery after operation will be possible by using it to a patient. When such a porous member 22 is arranged on the outer surface of the compact member 21, compatibleness with a bone is fast and integrated at an early stage. [0230] The compact member 21 is not readily compatible only in itself because of a gap or deviation even though it is buried into a bone, but because the porous member 22 having a specific pore shape is installed thereon, compatibleness with a bone is remarkably accelerated. Further, the strength is maintained by the compact member 21 (compared with the biomember comprised wholly of porous substances). [0231] That is, blood or cells are easily impregnated into pores. Also, regeneration of a bone can be promoted. Further, the member has no directional property and is easy to maintain the strength. Further, it is possible to enlarge the area where cells are attached. [0232] Further, because a part or the whole of the outer surface of the compact member 21 is comprised of the porous member 22, it is possible to enlarge the surface area of pores while maintaining the strength and to promptly regenerate a bone. Also, body fluid is impregnated everywhere. Also, in addition to body fluid, cells also infiltrate easily into pores. Also, a penetrating amount of oxygen, nutrients, cells, etc. are preferably markedly increased. Further, circulation of body fluid becomes better in the whole biomember, and cells are easy to infiltrate into a core part of the biomember. [0233] Further, circulation of body fluid into a pore becomes active. Also, pressure forming is not needed, there is no directional property that pores become flat, and simultaneously, compared with a member in which a contact point of urethane is opened, a communicating pore becomes remarkably large, and simultaneously, a surface area can be enlarged. [0234] In a dry state, it is possible to wet the whole by dropping water and blood. Also, even in a dry state without pretreatment, for example, once a part is immersed into water, water can be soaked by a capillary phenomenon. Also, it has characteristics such that it is possible to flow through an inner part to reach a bottom part by dropping water. Also, it is possible to be used for a living body without pretreatment. [0235] Because a calcium phosphates sintered body is different from metal or other kinds of ceramics in thermal expansion coefficient etc., fusion or bonding is often difficult, but the fusion or bonding can be easily performed by installing an intermediate layer. [0236] Further, the fusion or bonding of various materials can be easily performed by the intermediate layer. The integration of a bone with the biomember can be made earlier. [0237] Embodiments of FIGS. 16-23 [0238]FIG. 16 shows a biomember used for the portion which should be excised due to disease or injury. [0239] For example, the portion which should be excised due to disease or injury is removed previously by operation, and depending on the conditions of the defected portion, a biomemeber having an appropriate size and shape is prepared. At this time, the shape and size of the biomember are selected so that the outer surface of a bone becomes a compact part 31, and are processed, if necessary. In insertion, a porous part 32 is placed on an inner part of a bone, and the compact part 31 is placed in such a way as to form the same side as the outer surface of the bone. [0240] At that time, a splint is held to the compact part 31 to reduce stroke, and is put little by little while tapping by a plastic hammer etc. The surface of the porous part 32 may be slightly broken by contact with a bone, but because broken powder functions to fill up the rest of a space, and on the contrary, it is more preferable than the remaining of the rest of a space between the bone and the biomember. The compact part 31 resists strike-installation, and thus, it is difficult that the strike side is crushed. Also, it is good for the member to always maintain the shape as a whole and form the outer surface of the bone. The compact part 31 may be cracked by stroke, however, since there is no case that it is crushed to pieces, it does not affect the recovery after operation. [0241] It is preferable that the compact part 31 is a compact body of apatite. [0242] According to the degree of load in burying or using a biomember, if necessary, metal of titanium etc. or ceramics of alumina etc. may be used, or metal of titanium etc. or ceramics of alumina etc. which are coated with apatite may be used for the compact part 31 in replace of the compact body of apatite. [0243] The porous part 32 of the biomember is formed by foaming a slurry, fixing bubbles and sintering. At this time, it is preferable that calcium phosphate particles of slurry raw material have a mean particle diameter of a submicron order (i.e., not less than 0.1 μm and up to 1 μm) and the maximum diameter is also preferably of a submicron order. [0244] Further, it may be prepared by using two kinds of slurrys different in foaming amount. Also, it may be possible that the compact part 31 is previously formed by a common method for forming fine ceramics and a foamed slurry flows thereon to be fixed. Also, the compact part 31 and porous part 32 formed separately may be bonded before or after sintering and fixed. In this case, an intermediate layer having intermediate property may be disposed between the compact part 31 and the porous part 32. [0245] A pore is formed in substantially globular shape, but in case where communicating pores are formed in the interface by connecting with adjacent pores, a flat configuration becomes the similar configuration to an outline when two circles are caused to overlap partially with each other. Using such a shape is intended to enlarge a surface area. A communicating pore which is the boundary of pores of the biomember of the present invention is remarkably large compared with those by baking and taking-out of beads, and simultaneously, even after sintering, an edge remains sharply on a circumference of the communicating pore. [0246] The edge may be removed slightly by etching etc. so as to easily flow body fluid such as blood etc. [0247] The pore diameter of the present invention can be measured, for example, by resin embedding. And, the 50% volume pore diameter (i.e., a diameter of a pore when the value is exactly 50% of the total pores by integrating volumes in a large pore or a small pore) is referred to as the mean pore diameter. [0248] In the member of the present invention, since pores are connected with each other through a large communicating pore, an inner part of the member begins to be substituted promptly for a bone. Since blood is penetrated fast over the whole, centering around pores having a size larger than the mean pore diameter, blood etc. are penetrated similarly to large pores in small pores having a size smaller than the mean pore diameter. [0249] In the porous part 32 of the biomember of the present invention, the maximum pore diameter is preferably within three times of the mean pore diameter. A locally too large pore is not preferable in strength and cell adhesion. Preferably, it is within two times thereof. [0250] The graphs of FIG. 13 and FIG. 14 also accord with the embodiments of FIGS. 16-23. As the graphs, in the porous part 32, it is preferable that not less than 50% of total pores are included within a range of �30% of the mean pore diameter. Also, a cumulative volume fraction of a pore of not more than 20 μm is preferably approximately 0, and further, even if a skeleton surface of the porous part 32 (calcium phosphate porous body) is observed microscopically, there hardly exist pores, and it is preferable that there exists only unevenness due to rounding of calcium phosphate particles. [0251] Further, as such, according to the present invention, various materials etc. suitable for forming bones can be coated in the pore inner surface by using such features that the surface area is large so that blood etc. are easy to infiltrate into an inner part as a whole. [0252] The coated materials are at least one of the active materials such as cell adhesion promoting material, cell proliferation promoting material, osteogenesis promoting material, bone absorption inhibiting material, vascularization promoting material and so forth, cells and genetic recombinant cells. [0253] They are in a liquid phase or cultured in a broth, and infiltrate everywhere by using the features of the biomember of the present invention. In general, they are easily penetrated over the whole by immersion, but when cells become big or have a high viscosity owing to cell culture, they can be sucked by applying a negative pressure on a side where the biomember is present. In any case, by using the biomember of the present invention having both excellent penetrating property over the whole and excellent adhesive property to the surface, they can be penetrated uniformly and consistently to a core part even in a thick member which was impossible in the conventional product. [0254]FIG. 17 shows the other embodiment. A porous part 32 is a cylindrical body, and a compact part 31 becomes a cylinder held and installed in an inner part of the porous part 32. In this case, because the compact part 31 is formed in the inner part, in case where heavy load is applied, it is suitable to support load applied from the exterior. That is, while the outer surface of the porous part 32 in the outer surface is substituted for and regenerated to a bone and strength is occurred, it can protect the porous part 32 and maintain the strength of the biomember. [0255] Since the compact part 31 is formed in the inner part of the porous part 32, the compact part 31 plays a role in supporting load and protecting the porous part 32. In this case, it is preferable that the compact part 31 is a compact body of apatite. [0256]FIG. 18 also shows still other embodiment. The whole shape is a circular cone, the bottom surface is a compact part 31, and an apex side is a porous part 32. The shape is often used in actual operation. And, the biomember can be struck and installed by tapping the compact part 31. [0257]FIG. 19 also shows still other embodiment. A compact part 31 is a cylindrical body, and a porous part 32 becomes a cylinder installed in an inner part of the cylindrical body in a receivable shape. For example, a porous cylinder is inserted into a compact cylindrical body by tapping, and integrated. In this case, for instance, an intermediate part of a bone of rhabdome such as a femur, humerus, etc. is preferably comprised of only the biomember of the present invention. [0258]FIG. 20 also shows still other embodiment. The whole shape is cuboid, and only one side of outer surfaces becomes a compact part 31. For example, it is preferably suitable to bury the biomember of the present invention into a part of a large bone. [0259]FIG. 21 also shows still other embodiment. A compact part 31 is formed in a part of the outer surface and an inner part. Specifically, the whole shape is a circular cone, and the bottom surface is the compact part 31. And, in a direction toward the inner part from a stroke part (the bottom), the compact part 31 is vertically installed. [0260] By the above-mentioned constitutions, for example, when it is buried into a bone, the compact part 31 can be inserted by tapping. Also, while the porous part 32 of outer surface is substituted for a bone, the strength of the biomember can be maintained. Also, toward the inner part from the stroke part, the compact part 31 is vertically installed, and thus, stroke power is efficiently transmitted to the inner part. [0261]FIG. 22 also shows still other embodiment. The whole shape is columnar, and a compact part 31 is installed in an outercurved side and innercurved side of a porous part 32 having a substantially cylindrical shape. And, the compact part 31 in the outercurved and innercurved sides of the porous part 32 having a substantially cylindrical shape is connected to a branched part 35 installed in a radial direction at predetermined height. [0262] By the construction of FIG. 22, for example, when it is buried into a bone, of the compact part 31, the compact part 31 in the innercurved side of the porous part 32 having a substantially cylindrical shape is preferably inserted by tapping. Also, while the porous part 32 is substituted for a bone, the strength of the biomember is preferably maintained. [0263]FIG. 23 also shows still other embodiment. The whole shape is substantially conical, and an ampulla 34 of a porous substance is installed in the vicinity of an apex of the conical body. When it is inserted to bone, a part of the ampulla 34 is trimmed. Thereby, the rest of space can be filled. [0264] Examples will be illustrated with reference to the embodiments of FIGS. 16-23 of the present invention. EXAMPLE 11 [0265] A biomember was prepared to be a cone comprised of apatite 100% and having approximately a diameter of 20 mm and a height of 26 mm from the bottom surface and a porous part (porous part 32) having a porosity of 75% and a pore shape like FIG. 1 and a mean pore diameter of 300 μm, and compact part (compact part 31) having a porosity of 10%. The compact part was used for the bottom only by a thickness of 3 mm, and the other part was the porous part. [0266] This was inserted while lightly tapping the compact body by a plastic hammer into a hole of a diameter of 20 mm and a height of 25 mm of the bottom surface correctly formed in metal. The compact part could be completely inserted without smash. As a result of offtake after insertion, in the lateral side of the cone, a part of the porous substance part was crushed to powders, and the lateral side of the cone was suitable for the hole of the metal mold. 0.5 ml of blood dropped on the taken-out conical body, and it was entirely absorbed immediately in the porous part as if it drops on a sponge. Comparative Example 2 Relative to Example 11 [0267] Similarly to example 11, a cone (a diameter of the bottom surface is approximately 20 mm) without a compact part and comprised of only a porous part was inserted to a metal mold by tapping, and therefore, it was the same that a slant part was crushed partially to powders, but a part of stroke part was also crushed to powders. 0.5 ml of blood dropped on the taken-out conical body, it was entirely absorbed immediately in the porous part as if it drops on sponge. EXAMPLE 12 [0268] A cylindrical body of compact apatite having a diameter of 25 mm, an inner diameter of 20 mm and a height of 37.5 mm was prepared, and an apatite slurry was filled therein for forming a porous part, dried and sintered. A completed sintered body was a cylindrical body having a porosity of 75% of porous part, a diameter of 20 mm and a height of 20 mm. The sintered body endured up to 200 MPa against compression from the upper and lower sides. EXAMPLE 13 [0269] A cylindrical body of a compact apatite sintered body having a diameter of 20 mm, an inner diameter of 14 mm and a height of 20 mm was prepared, and a cylindrical body comprising a porous sintered body made of an apatite slurry and having a diameter of 14.1 mm and a height of 20 mm was inserted therein. The sintered body endured up to 280 MPa against compression from the upper and lower sides. Comparative Example 3 Relative to Examples 12 and 13 [0270] A cylindrical body of a porous apatite sintered body having a diameter of 20 mm, a height of 30 mm and s porosity of 75% was prepared. The sintered body endured up to 17 MPa against compression from the upper and lower sides. [0271] As such, in the biomember of the present invention, substantially globular pores are formed in the porous part 32, meanwhile, a number of large communicating pores are secured, and therefore, a surface area per unit volume is remarkably large, body fluid is penetrated into an inner part by a capillary phenomenon, the proportion of contact with blood is high, and thus, much more cells can be easily attached. [0272] Further, because active materials can be penetrated over the whole and be easily attached on the surface, it is easy to prepare to attach various active materials and introduce cells, and thereafter, culture becomes easy, and recovery after operation becomes possible by using it to a patient. [0273] The biomember of the present invention can be used when a bone is defected, and further, be applied to sustained-release preparations which release drugs for a long period by putting it in vivo. Also, though the compact biomember may be arranged properly in order to enhance the strength on core part of the biomember, circulation of body fluid is possible only in the porous part 32. [0274] In the porous part 32, blood or cells are easily impregnated into a pore. Also, regeneration of a bone can be promoted. Further, since it has the compact part 31, it is easy to maintain the strength. Also, the surface area to which cells are attached can be enlarged. And, since it has both the porous part 32 and the compact part 31, it is possible to enlarge the surface area of pores while maintaining the strength and to regenerate the bone promptly. [0275] In the porous part, body fluid is impregnated everywhere. Also, in addition to the body fluid, cells also infiltrate easily into pores. Also, the penetrating amounts of oxygen, nutrients, cells etc. are preferably quite increased. Further, circulation of body fluid becomes better in the whole biomember, and thus, cells easily infiltrate into a core part of the biomember. [0276] Further, in a dry state, the porous part can wet the whole by dropping water and blood. Also, even in a dry state without pretreatment, for example, once a part is immersed into water, it can soak water by a capillary phenomenon. Further, it is possible to flow through an inner part to reach a bottom part by dropping water. Also, it can be used for a living body without pretreatment. Meanwhile, since the compact part is suppressed to have a lower porosity, the strength is enhanced. Also, it can sufficiently take the porous part 32 substituted for a bone. For example, bending strength becomes about 80-150 MPa, and therefore, heavy load is applied. Thereby, it can endure stroke and its handling becomes much easier in operation etc. Also, it becomes the strength enough to sustain load applied by a bone of a patient. [0277] If it is prepared by a method of foaming a slurry, maintaining a pore shape characterized in that substantially globular communicating pores are numerous and large, it is easy to control a pore diameter. [0278] Among calcium phosphates sintered bodies, because hydroxyapatite exhibits particularly excellent strength, heavy load may be applied. Likewise, it can endure stroke, and its handling becomes even easier in operation etc. Also, it becomes strength enough to sustain the load applied by a bone of a patient. [0279] When it is used as sustained release preparations, by adjusting surface proportion of the compact part 31, a sustained-releasing amount of drugs can be controlled, and drugs have directional property in elution. Descriptions of FIGS. 24-26 which are common to all of the above-mentioned embodiments. [0280]FIG. 24 is a photomicrograph enlarging a cross section of the biomember in FIG. 1. [0281]FIG. 25 is a photomicrograph further enlarging a cross section of the biomember in FIG. 24. [0282]FIG. 26 is a photomicrograph further enlarging a cross section of the biomember in FIG. 25. [0283] The present invention is not limited to the above-mentioned embodiments. Referenced byCiting PatentFiling datePublication dateApplicantTitleUS7153938May 6, 2005Dec 26, 2006National Institute For Materials ScienceCross-linked apatite/collagen porous body containing self-organized apatite/collagen composite and its production methodUS7699612Aug 18, 2004Apr 20, 2010Yasumasa AkagawaMethod for fixing an implant, fixing member for the implant and implant compositeUS8032113 *Oct 18, 2007Oct 4, 2011Ubiquity Holdings, IncValue added transaction gateway for video clipsUS8039090May 26, 2004Oct 18, 2011Hoya CorporationPorous composite containing calcium phosphate and process for producing the sameUS8101268 *Aug 12, 2004Jan 24, 2012University Of BathBone substitute materialUS8137408Oct 30, 2007Mar 20, 2012Depuy Spine, Inc.Autologous bone graft materialUS8313742Mar 29, 2002Nov 20, 2012Depuy Acromed, Inc.Cell-containing bone graft materialUS8399409Jan 12, 2012Mar 19, 2013Biomimetic Therapeutics Inc.Compositions and methods for arthrodetic proceduresUS8546334 *Mar 27, 2002Oct 1, 2013Scil Technology GmbhDevice having osteoinductive and osteoconductive propertiesUS8603184Apr 2, 2003Dec 10, 2013DePuy Synthes Products, LLCKneadable and pliable bone replacement materialUS8864825 *Dec 10, 2010Oct 21, 2014Skulle Implants OyImplant systemUS20110166672 *Jun 29, 2009Jul 7, 2011The University Of TokyoBone defect filler not adsorbing bone growth factor and not inhibiting the activity of the sameUS20120277743 *Dec 10, 2010Nov 1, 2012Pekka VallittuImplant systemEP1504776A1 *May 12, 2003Feb 9, 2005Mmt Co., LtdMember for regenerating joint cartilage and process for producing the same, method of regenerating joint cartilage and aritficial cartilage for transplantationWO2003094987A1 *May 12, 2003Nov 20, 2003Mmt Co LtdMember for regenerating joint cartilage and process for producing the same, method of regenerating joint cartilage and aritficial cartilage for transplantationWO2003104386A1 *May 21, 2003Dec 18, 2003Mbs CorporationCulture apparatus, artificial tissue and blood preparationWO2004041319A1 *Nov 7, 2003May 21, 2004Toshio MatsumotoTherapeutic device for osteogenesis* Cited by examinerClassifications U.S. Classification623/16.11International ClassificationA61L27/38, A61L27/12, A61L27/56Cooperative ClassificationA61L27/3847, A61L27/3804, A61L27/56, A61L27/12European ClassificationA61L27/38D2B, A61L27/38B, A61L27/12, A61L27/56Legal EventsDateCodeEventDescriptionMay 15, 2001ASAssignmentOwner name: MMT CO., LTD., JAPANFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OCHI, TAKAHIRO;REEL/FRAME:011817/0600Effective date: 20010413Owner name: OCHI, TAKAHIRO, JAPANFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OCHI, TAKAHIRO;REEL/FRAME:011817/0600Effective date: 20010413Owner name: TOSHIBA CERAMICS CO., LTD., JAPANFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OCHI, TAKAHIRO;REEL/FRAME:011817/0600Effective date: 20010413RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services